Evidence map›Paper›PMID 41562925›Full record

ArticleMedical sciences (Basel, Switzerland)2026

Prognostic Value of Serial Lactate Measurement in Pediatric Cardiac Surgery Patients with Congenital Heart Disease in Southeast Mexico.

Ely Sanchez-Felix, Amonario Olivera-Mar, Miguel Santaularia-Tomas, Joan Johnson-Herrera, Laura Ortiz-Vera, Adrian Perez-Navarrete, Marcos Rivero-Peraza, Nina Mendez-Dominguez

Abstract read
In one paragraph

Article in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ely Sanchez-FelixHospital Regional de Alta Especialidad de la Peninsula de Yucatan, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Merida 97300, Mexico.
Amonario Olivera-MarHospital Regional de Alta Especialidad de la Peninsula de Yucatan, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Merida 97300, Mexico.
Miguel Santaularia-TomasHospital Regional de Alta Especialidad de la Peninsula de Yucatan, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Merida 97300, Mexico.
Joan Johnson-HerreraHospital Regional de Alta Especialidad de la Peninsula de Yucatan, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Merida 97300, Mexico.
Laura Ortiz-VeraHospital Regional de Alta Especialidad de la Peninsula de Yucatan, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Merida 97300, Mexico.
Adrian Perez-NavarreteHospital Regional de Alta Especialidad de la Peninsula de Yucatan, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Merida 97300, Mexico.ORCID 0000-0002-0745-7316
Marcos Rivero-PerazaHospital Regional de Alta Especialidad de la Peninsula de Yucatan, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Merida 97300, Mexico.ORCID 0009-0002-6874-2468
Nina Mendez-DominguezHospital Regional de Alta Especialidad de la Peninsula de Yucatan, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Merida 97300, Mexico.ORCID 0000-0002-0230-0731

Funding

IMSS/BIENESTAR PP006
6 · The paper itself

Abstract

BACKGROUND/

objectivesLactate, traditionally considered a byproduct of anaerobic metabolism, is increasingly recognized as a biomarker of tissue perfusion and systemic stress. While hyperlactatemia is frequent after pediatric cardiac surgery, evidence regarding its prognostic role remains controversial. This study aimed to evaluate whether serial lactate measurements predict mortality in children undergoing surgery for congenital heart disease in Southeast Mexico.

methodsWe conducted a retrospective cohort study including children aged 0-210 weeks with confirmed congenital heart disease who underwent first-time cardiac surgery between January 2022 and December 2024. Serum lactate was measured intraoperatively, at intensive care unit (ICU) admission, and at 12 and 24 h postoperatively using a Gem

results103 patients were included (median age 49.2 weeks; 60% female). Lactate levels overlapped intraoperatively but significantly discriminated against survivors from non-survivors thereafter. ICU admission lactate ≥ 4.2 mmol/L predicted mortality with 100% sensitivity and 60% specificity (AUC = 0.84). Hazard ratios confirmed that lactate at ICU admission (HR 2.17, 95% CI 1.16-4.06;

conclusionsSerial lactate monitoring, particularly upon ICU admission, provides strong prognostic information for in-hospital mortality in pediatric cardiac surgery patients. Incorporating early postoperative lactate into routine monitoring may allow timely therapeutic adjustments. Preoperative lactate assessment warrants further evaluation as a potential risk stratification tool.

Indexed as

Cardiac Surgical ProceduresHeart Defects, CongenitalLactic AcidBiomarkersChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMexicoPrognosisRetrospective StudiesBiomarkersLactic Acidcardiac surgical procedurescongenital heart defectsintensive care unitsprospective studies

Identifiers

PMID41562925
PMCPMC12821506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.